- Home
- RZLT vs HRTX Comparison
RZLT vs HRTX Comparison
Compare RZLT & HRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RZLT
- HRTX
- Stock Information
- Founded
- RZLT 2010
- HRTX 1983
- Country
- RZLT United States
- HRTX United States
- Employees
- RZLT N/A
- HRTX N/A
- Industry
- RZLT Biotechnology: Pharmaceutical Preparations
- HRTX Biotechnology: Pharmaceutical Preparations
- Sector
- RZLT Health Care
- HRTX Health Care
- Exchange
- RZLT Nasdaq
- HRTX Nasdaq
- Market Cap
- RZLT 819.3M
- HRTX 242.0M
- IPO Year
- RZLT N/A
- HRTX 1987
- Fundamental
- Price
- RZLT $9.49
- HRTX $1.19
- Analyst Decision
- RZLT Strong Buy
- HRTX Strong Buy
- Analyst Count
- RZLT 6
- HRTX 2
- Target Price
- RZLT $14.50
- HRTX $4.50
- AVG Volume (30 Days)
- RZLT 1.5M
- HRTX 1.5M
- Earning Date
- RZLT 11-07-2025
- HRTX 11-04-2025
- Dividend Yield
- RZLT N/A
- HRTX N/A
- EPS Growth
- RZLT N/A
- HRTX N/A
- EPS
- RZLT N/A
- HRTX N/A
- Revenue
- RZLT N/A
- HRTX $149,694,000.00
- Revenue This Year
- RZLT N/A
- HRTX $10.62
- Revenue Next Year
- RZLT N/A
- HRTX $12.99
- P/E Ratio
- RZLT N/A
- HRTX N/A
- Revenue Growth
- RZLT N/A
- HRTX 9.78
- 52 Week Low
- RZLT $2.22
- HRTX $1.04
- 52 Week High
- RZLT $10.04
- HRTX $2.68
- Technical
- Relative Strength Index (RSI)
- RZLT 59.75
- HRTX 39.59
- Support Level
- RZLT $9.00
- HRTX $1.16
- Resistance Level
- RZLT $9.89
- HRTX $1.25
- Average True Range (ATR)
- RZLT 0.58
- HRTX 0.07
- MACD
- RZLT 0.01
- HRTX -0.01
- Stochastic Oscillator
- RZLT 81.06
- HRTX 13.64
About RZLT Rezolute Inc. (NV)
Rezolute Inc is a clinical-stage biopharmaceutical company focused on developing therapies for rare and metabolic diseases. The company aims to address unmet medical needs in conditions like congenital hyperinsulinism, a rare endocrine disorder causing excessive insulin production and resulting hypoglycemia. Rezolute's pipeline includes drug candidates designed to improve patient outcomes while reducing treatment burdens. The company engages in research, development, and clinical trials to advance its therapies and collaborates with medical communities and patient groups to support its objectives. Revenue and value creation depend largely on successful product development and regulatory approvals.
About HRTX Heron Therapeutics Inc.
Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.